![Validity of the online PREDICT tool in older patients with breast cancer: a population-based study | British Journal of Cancer Validity of the online PREDICT tool in older patients with breast cancer: a population-based study | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2015.466/MediaObjects/41416_2016_Article_BFbjc2015466_Fig1_HTML.jpg)
Validity of the online PREDICT tool in older patients with breast cancer: a population-based study | British Journal of Cancer
![Frontiers | A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With de novo Distant Metastasis Frontiers | A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With de novo Distant Metastasis](https://www.frontiersin.org/files/Articles/512973/fonc-10-00014-HTML/image_m/fonc-10-00014-g001.jpg)
Frontiers | A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With de novo Distant Metastasis
Evaluation of machine learning algorithms for the prognosis of breast cancer from the Surveillance, Epidemiology, and End Results database | PLOS ONE
![Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S095980491730833X-gr3.jpg)
Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect
![Variability Among Breast Cancer Risk Classification Models When Applied at the Level of the Individual Woman | Journal of General Internal Medicine Variability Among Breast Cancer Risk Classification Models When Applied at the Level of the Individual Woman | Journal of General Internal Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs11606-023-08043-4/MediaObjects/11606_2023_8043_Fig2_HTML.png)
Variability Among Breast Cancer Risk Classification Models When Applied at the Level of the Individual Woman | Journal of General Internal Medicine
![Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study | The BMJ Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study | The BMJ](https://www.bmj.com/content/bmj/381/bmj-2022-073800/F2.medium.jpg)
Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study | The BMJ
![PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants | npj Breast Cancer PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants | npj Breast Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41523-023-00546-x/MediaObjects/41523_2023_546_Fig3_HTML.png)
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants | npj Breast Cancer
![PDF) Development and validation of the PORTRET tool to predict recurrence, overall survival, and other-cause mortality in older patients with breast cancer in the Netherlands: a population-based study PDF) Development and validation of the PORTRET tool to predict recurrence, overall survival, and other-cause mortality in older patients with breast cancer in the Netherlands: a population-based study](https://i1.rgstatic.net/publication/355896949_Development_and_validation_of_the_PORTRET_tool_to_predict_recurrence_overall_survival_and_other-cause_mortality_in_older_patients_with_breast_cancer_in_the_Netherlands_a_population-based_study/links/61833c0d0be8ec17a96a25d3/largepreview.png)
PDF) Development and validation of the PORTRET tool to predict recurrence, overall survival, and other-cause mortality in older patients with breast cancer in the Netherlands: a population-based study
![A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients - eBioMedicine A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients - eBioMedicine](https://www.thelancet.com/cms/attachment/1a9663a2-8382-4fb4-b315-eba9de3e7932/gr1_lrg.jpg)
A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients - eBioMedicine
![Development and validation of the PORTRET tool to predict recurrence, overall survival, and other-cause mortality in older patients with breast cancer in the Netherlands: a population-based study - The Lancet Healthy Longevity Development and validation of the PORTRET tool to predict recurrence, overall survival, and other-cause mortality in older patients with breast cancer in the Netherlands: a population-based study - The Lancet Healthy Longevity](https://www.thelancet.com/cms/attachment/4496b1a6-64cb-4d92-9c51-273d641d949f/gr1_lrg.jpg)
Development and validation of the PORTRET tool to predict recurrence, overall survival, and other-cause mortality in older patients with breast cancer in the Netherlands: a population-based study - The Lancet Healthy Longevity
![Integrated multiomics analysis and machine learning refine molecular subtypes and prognosis for muscle-invasive urothelial cancer: Molecular Therapy - Nucleic Acids Integrated multiomics analysis and machine learning refine molecular subtypes and prognosis for muscle-invasive urothelial cancer: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/33742944-e09f-4c3c-90f0-6c282d48474d/fx1_lrg.jpg)
Integrated multiomics analysis and machine learning refine molecular subtypes and prognosis for muscle-invasive urothelial cancer: Molecular Therapy - Nucleic Acids
![Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients - Zaguirre - 2021 - Cancer Medicine - Wiley Online Library Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients - Zaguirre - 2021 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2417e3fd-c30a-4e21-a5b1-714f4d29c75b/cam43713-fig-0002-m.jpg)
Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients - Zaguirre - 2021 - Cancer Medicine - Wiley Online Library
![Predicting factors for survival of breast cancer patients using machine learning techniques | BMC Medical Informatics and Decision Making | Full Text Predicting factors for survival of breast cancer patients using machine learning techniques | BMC Medical Informatics and Decision Making | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12911-019-0801-4/MediaObjects/12911_2019_801_Fig3_HTML.png)
Predicting factors for survival of breast cancer patients using machine learning techniques | BMC Medical Informatics and Decision Making | Full Text
![Improving the performance of support-vector machine by selecting the best features by Gray Wolf algorithm to increase the accuracy of diagnosis of breast cancer | Journal of Big Data | Full Text Improving the performance of support-vector machine by selecting the best features by Gray Wolf algorithm to increase the accuracy of diagnosis of breast cancer | Journal of Big Data | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs40537-019-0247-7/MediaObjects/40537_2019_247_Figa_HTML.png)
Improving the performance of support-vector machine by selecting the best features by Gray Wolf algorithm to increase the accuracy of diagnosis of breast cancer | Journal of Big Data | Full Text
![Correlation between Nottingham Prognostic Index and Adjuvant! Online prognostic tools in patients with early-stage breast cancer in Mid-Western Ireland. | Semantic Scholar Correlation between Nottingham Prognostic Index and Adjuvant! Online prognostic tools in patients with early-stage breast cancer in Mid-Western Ireland. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/70d7d50b1b6a4af217fb961b01fc37d2f56f6383/2-Table1-1.png)
Correlation between Nottingham Prognostic Index and Adjuvant! Online prognostic tools in patients with early-stage breast cancer in Mid-Western Ireland. | Semantic Scholar
![Interactive online consensus survival tool for esophageal squamous cell carcinoma prognosis analysis Interactive online consensus survival tool for esophageal squamous cell carcinoma prognosis analysis](https://www.spandidos-publications.com/article_images/ol/18/2/ol-18-02-1199-g03.jpg)
Interactive online consensus survival tool for esophageal squamous cell carcinoma prognosis analysis
![PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients | Breast Cancer Research | Full Text PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-022-01567-3/MediaObjects/13058_2022_1567_Fig4_HTML.png)
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients | Breast Cancer Research | Full Text
![Frontiers | Prediction of Breast Cancer Recurrence Using a Deep Convolutional Neural Network Without Region-of-Interest Labeling Frontiers | Prediction of Breast Cancer Recurrence Using a Deep Convolutional Neural Network Without Region-of-Interest Labeling](https://www.frontiersin.org/files/Articles/734015/fonc-11-734015-HTML/image_m/fonc-11-734015-g001.jpg)
Frontiers | Prediction of Breast Cancer Recurrence Using a Deep Convolutional Neural Network Without Region-of-Interest Labeling
![PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants | npj Breast Cancer PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants | npj Breast Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41523-023-00546-x/MediaObjects/41523_2023_546_Fig1_HTML.png)